DexCom, Inc.
DXCM
$61.14
$1.813.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.15% | 15.60% | 14.21% | 9.30% | 9.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.15% | 15.60% | 14.21% | 9.30% | 9.11% |
| Cost of Revenue | 10.22% | 16.64% | 22.17% | 20.94% | 19.04% |
| Gross Profit | 20.20% | 14.92% | 9.27% | 2.39% | 3.23% |
| SG&A Expenses | 4.23% | 0.40% | 2.77% | 2.41% | 5.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.65% | 9.24% | 12.39% | 11.07% | 11.59% |
| Operating Income | 63.36% | 51.97% | 23.84% | 0.84% | -2.92% |
| Income Before Tax | 64.70% | 53.51% | 28.92% | -2.83% | -6.12% |
| Income Tax Expenses | 39.67% | 89.83% | 277.65% | 51.86% | 40.62% |
| Earnings from Continuing Operations | 73.84% | 45.14% | 5.86% | -14.30% | -16.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.84% | 45.14% | 5.86% | -14.30% | -16.28% |
| EBIT | 63.36% | 51.97% | 23.84% | 0.84% | -2.92% |
| EBITDA | 50.65% | 42.30% | 21.62% | 4.12% | 1.10% |
| EPS Basic | 76.13% | 46.45% | 5.66% | -14.95% | -17.86% |
| Normalized Basic EPS | 65.89% | 55.59% | 29.51% | -2.96% | -7.32% |
| EPS Diluted | 75.52% | 46.92% | 7.71% | -11.97% | -14.00% |
| Normalized Diluted EPS | 67.13% | 56.85% | 31.85% | 0.42% | -2.75% |
| Average Basic Shares Outstanding | -1.28% | -0.84% | -0.18% | 0.51% | 1.78% |
| Average Diluted Shares Outstanding | -2.02% | -1.72% | -1.80% | -2.60% | -2.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |